RhumbLine Advisers’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76K | Sell |
2,379
-87,315
| -97% | -$101K | ﹤0.01% | 3967 |
|
|
2025
Q1 | $121K | Sell |
89,694
-2,886
| -3% | -$3.9K | ﹤0.01% | 3319 |
|
|
2024
Q4 | $1.22M | Sell |
92,580
-2,117
| -2% | -$27.9K | ﹤0.01% | 2143 |
|
|
2024
Q3 | $1.06M | Sell |
94,697
-1,791
| -2% | -$20.1K | ﹤0.01% | 2238 |
|
|
2024
Q2 | $1.04M | Buy |
96,488
+14,662
| +18% | +$158K | ﹤0.01% | 2221 |
|
|
2024
Q1 | $1.22M | Buy |
81,826
+1,212
| +2% | +$18.1K | ﹤0.01% | 2142 |
|
|
2023
Q4 | $1.46M | Buy |
80,614
+1,517
| +2% | +$27.5K | ﹤0.01% | 2072 |
|
|
2023
Q3 | $1.37M | Buy |
79,097
+255
| +0.3% | +$4.42K | ﹤0.01% | 2038 |
|
|
2023
Q2 | $1.43M | Buy |
+78,842
| New | +$1.43M | ﹤0.01% | 2097 |
|
|
2022
Q2 | – | Sell |
-22,867
| Closed | -$160K | – | 3202 |
|
|
2022
Q1 | $160K | Buy |
22,867
+523
| +2% | +$3.66K | ﹤0.01% | 2802 |
|
|
2021
Q4 | $302K | Sell |
22,344
-416
| -2% | -$5.62K | ﹤0.01% | 2701 |
|
|
2021
Q3 | $384K | Buy |
22,760
+995
| +5% | +$16.8K | ﹤0.01% | 2670 |
|
|
2021
Q2 | $634K | Sell |
21,765
-2,282
| -9% | -$66.5K | ﹤0.01% | 2448 |
|
|
2021
Q1 | $946K | Buy |
24,047
+13,798
| +135% | +$543K | ﹤0.01% | 2214 |
|
|
2020
Q4 | $233K | Buy |
+10,249
| New | +$233K | ﹤0.01% | 2772 |
|